IMCD NV (CHIX:IMCDA) YoY EBITDA Growth: 11.41% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:IMCDA IMCD NV CHIX:IMCDA
78 GF Score
Price €79.78
GF Value €153.19
Valuation Significantly Undervalued
! 9 Warning Signs
View Full Analysis

What is IMCD NV YoY EBITDA Growth?

IMCD NV CHIX:IMCDA 78 YoY EBITDA Growth is 11.41% as of Jun. 2026. GuruFocus rates CHIX:IMCDA with a GF Score™ of 78/100 and a GF Value™ of €153.19 (Significantly Undervalued). The stock has 9 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. IMCD NV's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 11.41%.

IMCD NV's EBITDA per Share for the six months ended in Jun. 2026 was €5.21.

IMCD NV YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for IMCD NV's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMCD NV YoY EBITDA Growth Chart

IMCD NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.63 45.51 -1.46 3.36 -17.16

IMCD NV Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 3.84 -9.75 -24.75 11.41
CHIX:IMCDA
78GF Score
IMCD NV CHIX:IMCDA
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IMCD NV YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

IMCD NV's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(8.522-10.287)/ | 10.287 |
=-17.16 %

IMCD NV's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(5.205-4.672)/ | 4.672 |
=11.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 11.41% mean?
IMCD NV (CHIX:IMCDA) has a YoY EBITDA Growth of 11.41% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for IMCD NV and its competitors.
Is IMCD NV's YoY EBITDA Growth too high?
IMCD NV's current YoY EBITDA Growth is 11.41%. Overall, IMCD NV has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IMCD NV's YoY EBITDA Growth compare to LIN and SHW?
IMCD NV's YoY EBITDA Growth of 11.41% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Chemicals company?
A good YoY EBITDA Growth depends on the Chemicals industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for IMCD NV and its competitors. IMCD NV's current YoY EBITDA Growth is 11.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMCD NV stock overvalued right now?
Based on GuruFocus' analysis, IMCD NV (CHIX:IMCDA) is currently considered Significantly Undervalued. The stock's GF Value™ is €153.19, compared to a current price of €79.78 — trading 47.9% below its estimated fair value. The current YoY EBITDA Growth is 11.41%. IMCD NV's overall GF Score™ is 78/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For IMCD NV (CHIX:IMCDA), the current YoY EBITDA Growth is 11.41% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IMCD NV (CHIX:IMCDA) Overvalued in 2026?

Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued. The current stock price of €79.78 is trading 47.9% below its estimated GF Value™ of €153.19. GuruFocus considers IMCD NV to be Significantly Undervalued.

Key valuation signals for CHIX:IMCDA:

  • YoY EBITDA Growth: 11.41%
  • GF Value™: €153.19 vs. price of €79.78 (47.9% below fair value)
  • GF Score™: 78/100 with 9 warning signs

No single metric tells the full story. See the CHIX:IMCDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IMCD NV Business Description

Address Wilhelminaplein 32, Rotterdam, NLD, 3072 DE
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
78GF Score

Get the complete analysis for CHIX:IMCDA

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€79.78
Price
€153.19
GF Value